ISB News

Arab Spring for Biology? Choose Open Access

This weekend, Burak Kutlu, one of our research scientists in the Hood Lab, is attending the Sage Bionetworks Commons Congress in San Francisco. The Congress will focus on "Building Better Models of Disease Together: Moving beyond the current medical information system and its rewards." He was selected as an outstanding Young Investigator. Here's his statement on why open access is important:

"The economics performing open science is not well defined. One of the reasons that we are failing to make major advancements in drug discovery is because most of the data sit behind walls until researchers decide to publish it. A pessimistic worldview dictates that the current failing system of new drug discovery will continue and there is no hope to change that. I am sure that a majority of the people living under dictatorship in Arab countries felt the same way, until some small group of people took leadership and finally managed to ignite a revolution that toppled the whole regimes. I would like to be part of the revolution to make open access mainstream and I look forward to the Sage Congress to network with people with the same agenda." – Burak Kutlu

Kutlu – whose work involves identifying gene regulatory networks involved in glioblastoma initiation and progression – will report on his experience at the Congress upon his return. Stay tuned.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.